One Year Later: The ABC Science Collaborative Provides Evidence that Helps To Open North Carolina Schools
North Carolina models the way for national discussion and decisions on school re-openings during COVID-19 pandemic.
Pragmatic Approaches Enable Lower Burden and Cost in DCRI-led Trial
The HiLo study seeks to determine the optimal phosphate level for patients with chronic kidney disease.
The ABCs of Keeping Kids Healthy
The below is a republication of a story that featured DCRI’s Kanecia Zimmerman, MD, MPH, which appeared in Duke University School of Medicine’s digital publication, Magnify.
Study Shows ‘Alarming Gaps’ in Treatment of Patients with Diabetes, Heart Disease
Over a third of patients with diabetes and heart disease were not taking any of the three therapies proven to prevent major adverse cardiovascular events.
DCRI Statistician Advocates for Open Science During COVID-19
A DCRI expert in open science and data sharing recently contributed to a letter to the editor voicing the importance of open science in COVID-19 research.
The letter, published recently in Therapeutic Innovation & Regulatory Science, was authored by DCRI’s Frank Rockhold, PhD, along with two other authors who were both funded by The Gates Foundation. The letter reviewed work already being undertaken by the International COVID-19 Data Research Alliance (ICODA) and provided recommendations for upcoming clinical trials for COVID-19 therapeutics and vaccines.
New Study Analyzes Secondary COVID-19 Transmission for In-Person Schooling
The rate of transmission within schools was found to be much lower than the rate of community spread of the disease.
Global Digital Health Expert, Eric Perakslis, PhD, to Join Duke Clinical Research Institute as Chief Science & Digital Officer
Perakslis will provide strategic vision and oversight of DCRI’s digital research initiatives and technology affairs to advance the academic institute’s clinical research portfolio.
DCRI, Verily, and HERO Registry to Support Long-Term Safety Study of COVID-19 Vaccine
The Duke Clinical Research Institute (DCRI) and Verily are utilizing the HERO Registry and community to launch a study to gain long-term insights about the COVID-19 vaccine developed by Pfizer and BioNTech, including real-world safety data. This study, which is funded by Pfizer, will follow vaccinated healthcare workers for two years to assess their experiences after receiving the vaccine.
Novel Blueprint Leverages Behavioral Economics to Inform Clinical Practice
Data from electronic health record (EHR) systems—including on prescribing patterns—are often not available to clinicians in an aggregated or easily digestible format.
Survey Designed by DCRI Gains Insight into COVID-19 Preferences
DCRI population health scientists conducted a discrete choice experiment to improve understanding of how people weigh risks associated with COVID-19. A partisan split in reaction to COVID-19 has been widely publicized in the media—but new research from DCRI population health scientists suggests that it may not be that simple.